Genome Editing: Promoting Responsible Research
- 10 Downloads
For more than 40 years, scientists have been developing tools and technologies for genome modification; however, initial progress was slow and few outside of the molecular biology community took an interest in the field. Everything has dramatically changed with the recent appearance of the so-called precision approaches, and especially with the ‘CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) revolution’. With great powers come great responsibilities. CRISPR-derived technologies have been proven efficient, cheap, rather easy and fast, and provided universal access to genome modification techniques beyond the leading research centers and reference laboratories. The popularization of techniques to manipulate the human genome and that of all other living beings consequently raises many essential questions, on the ethical and legal sides, both for the scientific community and the lay public. In order to mitigate excessive hype and concern among citizens, a call for the mobilization of the various stakeholders is now urgent through a global governance of genome editing.
Compliance with Ethical Standards
No funding was received for the preparation of this review.
Conflict of interest
François Hirsch, Christine Lemaitre, Hervé Chneiweiss and Lluis Montoliu are members of the Board of ARRIGE.
- 7.ClinicalTrials.gov. Studies involving genome editing. https://clinicaltrials.gov/ct2/results?cond=&term=genome+editing&cntry=&state=&city=&dist=&Search=Search. Accessed Feb 2019.
- 15.Convention on Human Rights and Biomedicine (Oviedo Convention). https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/164. Accessed Feb 2019.
- 16.Human Genome Editing Initative. http://nationalacademies.org/gene-editing/index.htm. Accessed Feb 2019.
- 17.International Summit on Human Genome Editing—He Jiankui presentation. 2018. https://www.youtube.com/watch?v=tLZufCrjrN0. Accessed Feb 2019.
- 20.ClinicalTrials.gov. A safety and efficacy study evaluating CTX001 in subjects with transfusion-dependent β-thalassemia. https://clinicaltrials.gov/ct2/show/NCT03655678. Accessed Feb 2019.
- 26.Radars Info Burkina. Lâcher de moustiques génétiquement modifiés au Burkina Faso : Est-ce la panacée pour l’éradication du paludisme? http://www.radarsburkina.net/index.php/societe/373-lacher-de-moustiques-genetiquement-modifies-au-burkina-faso-est-ce-la-panacee-pour-l-eradication-du-paludisme. Accessed Feb 2019.
- 31.International Summit on Human Genome Editing. 2015. http://nationalacademies.org/gene-editing/Gene-Edit-Summit/. Accessed Feb 2019.
- 32.UN Convention on Biodiversity to establish a moratorium on gene drives. http://www.etcgroup.org/content/160-global-groups-call-moratorium-new-genetic-extinction-technology-un-convention. Accessed Feb 2019.
- 33.Notes du Comité d’éthique en réponse aux saisines. https://www.inserm.fr/recherche-inserm/ethique/comite-ethique-inserm-cei/notes-comite-ethique-en-reponse-saisines. Accessed Feb 2019.
- 36.de Lecuona I, Casado M, Marfany G, et al. Gene editing in humans: towards a global and inclusive debate for responsible research. Yale J Biol Med. 2017;90(4):673–81.Google Scholar
- 37.Association for Responsible Research and Innovation in Genome Editing (ARRIGE). ARRIGE Kick-Off meeting. http://arrige.org/meeting1.php. Accessed Feb 2019.
- 38.Association for Responsible Research and Innovation in Genome Editing (ARRIGE). http://arrige.org. Accessed Feb 2019.
- 43.World Economic Forum. How should we regulate genome editing? https://www.weforum.org/agenda/2017/05/how-should-we-regulate-genome-editing/. Accessed Feb 2019.
- 44.National Academies of Sciences, Engineering and Medicine. On Human Genome Editing II: Statement by the Organizing Committee of the Second International Summit on Human Genome Editing. http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=11282018b. Accessed Feb 2019.
- 45.World Health Organisation. Human Genome editing. https://www.who.int/ethics/topics/gene-editing/en/. Accessed Feb 2019.